Nebivolol/valsartan
| Combination of | |
|---|---|
| Nebivolol | Beta blocker |
| Valsartan | Angiotensin II receptor blocker (ARB) |
| Clinical data | |
| Trade names | Byvalson, Vyduo |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| KEGG | |
Nebivolol/valsartan, sold under the brand name Byvalson among others, is a medication used to treat hypertension.[1][2]
It is available as a
generic medication.[3]
References
- ^ a b "Byvalson (nebivolol and valsartan) tablets, for oral use Initial U.S. Approval: 2016". DailyMed. Archived from the original on 24 September 2022. Retrieved 23 September 2022.
- from the original on 24 September 2022. Retrieved 24 September 2022.
- ^ "2022 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 March 2023. Archived from the original on 30 June 2023. Retrieved 30 June 2023.
Further reading
- Ishak J, Rael M, Punzi H, Gradman A, Anderson LM, Patel M, et al. (January 2018). "Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension". Journal of Clinical Hypertension. 20 (1): 143–149. PMID 29105958.
External links
- "Nebivolol hydrochloride mixture with valsartan". Drug Information Portal. U.S. National Library of Medicine.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |